Form 4: IDEX Corp Executive Melissa Flores Reports Stock Transactions
SEC Form 4 Filing
Melissa Flores, SVP, CHRO of IDEX Corp, reports acquisition and disposal of company stock on February 11, 2025.
Summary
- On February 11, 2025, Melissa Flores, SVP, CHRO of IDEX Corp, acquired 777 shares of common stock at a price of $196.45 per share.
- On the same day, she disposed of 377 shares of common stock at the same price of $196.45 per share.
- Following these transactions, Flores directly owns 1,651 shares of IDEX Corp common stock.
- The reported transactions also include 68 shares acquired under the Company's Employee Stock Purchase Plan between February 14, 2020 and February 3, 2025.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, as required by the SEC. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of company leadership.
Key Dates
| Date | Description |
|---|---|
| February 14, 2020 | Start date for shares acquired under the Company's Employee Stock Purchase Plan |
| February 3, 2025 | End date for shares acquired under the Company's Employee Stock Purchase Plan |
| February 11, 2025 | Date of stock acquisition and disposal by Melissa Flores |
| February 13, 2025 | Date of signature on the Form 4 filing |
Keywords
IDEX Corp, Melissa Flores, Stock Transactions, Form 4, Insider Trading, SVP, CHRO, Common Stock, Employee Stock Purchase Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.